methyl 4-((4-oxo-4H-chromen-3-yl)methyl)benzoate | 503040-23-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 高异黄酮
• 英文名称: methyl 4-((4-oxo-4H-chromen-3-yl)methyl)benzoate
• 英文别名: Methyl-4-(4-oxo-4H-chromen-3-ylmethyl)-benzoate；methyl 4-[(4-oxochromen-3-yl)methyl]benzoate
• CAS: 503040-23-1
• 化学式: C₁₈H₁₄O₄
• 分子量: 294.307
• InChiKey: DEILVEPPSHZRCR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 4-((4-oxo-4H-chromen-3-yl)methyl)benzoate 在 lithium hydroxide 作用下， 以 四氢呋喃 为溶剂， 生成
  参考文献：
  名称：

  N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors

  摘要：

  A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides were designed and synthesized. These compounds were shown to inhibit recombinant human HDAC I with IC50 values in the sub-micromolar range. In human cancer cells growing in culture these compounds induced hyperacetylation of histones, induced the expression of the tumor suppressor protein p21(WAF1/Cip1), and inhibited cellular proliferation. Certain compounds of this class also showed in vivo activity in various human tumor xenograft models in mice. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.10.050
• 作为产物：
  描述：

  4-(4-oxo-chroman-3-ylidenemethyl)-benzoic acid methyl ester 在 rhodium(III) chloride 作用下， 以 乙醇 为溶剂， 反应 16.0h， 以59%的产率得到methyl 4-((4-oxo-4H-chromen-3-yl)methyl)benzoate
  参考文献：
  名称：

  N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors

  摘要：

  A variety of N-(2-amino-phenyl)-4-(heteroarylmethyl)-benzamides were designed and synthesized. These compounds were shown to inhibit recombinant human HDAC I with IC50 values in the sub-micromolar range. In human cancer cells growing in culture these compounds induced hyperacetylation of histones, induced the expression of the tumor suppressor protein p21(WAF1/Cip1), and inhibited cellular proliferation. Certain compounds of this class also showed in vivo activity in various human tumor xenograft models in mice. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.10.050

文献信息

• Synthesis of 3-(2-Olefinbenzyl)-4<i>H</i>-chromen-4-one through Cyclobenzylation and Catalytic C–H Bond Functionalization Using Palladium(II)
  作者：Yu-Feng Lin、Chi Fong、Wan-Ling Peng、Kuei-Chien Tang、Yi-En Liang、Wen-Tai Li

  DOI：10.1021/acs.joc.7b01626

  日期：2017.10.20

  and benzyl bromide to produce homoisoflavonoid. The second step involves intermolecular Pd-catalyzed π-chelating-assisted C–H bond olefination. Using the C-2/C-3 double bond of chromone, palladium-catalyzed aryl C–H bond activation can be functionalized to generate ortho-olefination derivatives in moderate to high yields.

  开发了一种有效的策略，可以分两步合成3-（2-烯烃苄基）-4 H -chromen -4-one。第一步是（E）-3-（二甲基氨基）-1-（2-羟基苯基）丙-2-烯-1-酮与苄基溴之间的环苄基化反应，以生成均异黄酮。第二步涉及分子间Pd催化的π螯合辅助的C–H键烯化。使用色酮的C-2 / C-3双键，可以将钯催化的芳基C–H键活化功能化，以中等至高收率生成邻烯化衍生物。
• Inhibitors of histone deacetylase
  申请人：MethylGene, Inc.

  公开号：US20040142953A1

  公开（公告）日：2004-07-22

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  这项发明涉及抑制组蛋白去乙酰化酶。该发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。该发明还提供了用于治疗细胞增殖性疾病和病况的组合物和方法。
• [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS DE L'HISTONE DEACETYLASE
  申请人：METHYLGENE INC

  公开号：WO2004069823A1

  公开（公告）日：2004-08-19

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  该发明涉及抑制组蛋白去乙酰化酶的技术。该发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病症的组合物和方法。
• INHIBITORS OF HISTONE DEACETYLASE
  申请人：Methylgene, Inc.

  公开号：EP1429765A2

  公开（公告）日：2004-06-23
• US6897220B2
  申请人：——

  公开号：US6897220B2

  公开（公告）日：2005-05-24